Davison B J, Parker P A, Goldenberg S L
Prostate Centre at Vancouver General Hospital, Vancouver, British Columbia, Canada.
BJU Int. 2004 Jan;93(1):47-51. doi: 10.1111/j.1464-410x.2004.04553.x.
To assess patients' preferences about how physicians' deliver news of a prostate cancer diagnosis, and patients' preferred participation in medical decision-making, with a secondary objective being to validate the Measure of Patients' Preferences (MPP) scale with these patients.
Eighty-seven men (mean age 62.4 years) referred to an ultrasound/radiology department for their first transrectal ultrasonography (TRUS)-guided biopsy completed the MPP and Control Preferences measures. Patients were asked to identify how they would like to be told about a potential prostate cancer diagnosis by their physician, and what role they would like in making treatment-related decisions with their physicians.
Most patients wanted either an active (43%) or collaborative (47%) role in medical decision-making if the TRUS showed prostate cancer. Men rated content items (what and how much information is provided by their physician) as more important than supportive (emotional support during interaction) or facilitative (setting and context variables) items. Men who preferred a collaborative role in the patient-physician interaction wanted significantly (P = 0.04) more content (detailed information on available treatments and the effect of these treatments on their quality of life) than men who had a preference for either an active or passive role in medical decision-making. Demographic characteristics were not indicative of either preferred role in decision-making or communication preferences. The MPP was shown to be reliable.
Men have expectations about how physicians disclose a diagnosis of prostate cancer and how they wish to participate in making treatment decisions. These results underline the importance of identifying patient preferences before embarking on treatment discussions, as the way 'bad news' is disclosed has previously been identified as a predictor of the outcome of the patient-physician interview.
评估患者对于医生告知前列腺癌诊断消息方式的偏好,以及患者在医疗决策中倾向的参与方式,次要目的是在这些患者中验证患者偏好测量量表(MPP)。
八十七名男性(平均年龄62.4岁)因首次接受经直肠超声(TRUS)引导下活检而被转介至超声/放射科,他们完成了MPP和对照偏好测量。患者被问及希望医生如何告知其可能的前列腺癌诊断,以及他们希望在与医生共同做出治疗相关决策中扮演什么角色。
如果TRUS显示前列腺癌,大多数患者希望在医疗决策中扮演积极(43%)或协作(47%)的角色。男性认为内容项目(医生提供了什么信息以及多少信息)比支持性项目(互动期间的情感支持)或促进性项目(环境和背景变量)更重要。在医患互动中倾向于协作角色的男性比在医疗决策中倾向于积极或消极角色的男性显著(P = 0.04)需要更多内容(关于可用治疗及其对生活质量影响的详细信息)。人口统计学特征并未表明在决策或沟通偏好方面的首选角色。MPP显示是可靠的。
男性对于医生如何披露前列腺癌诊断以及他们希望如何参与治疗决策有期望。这些结果强调了在开始治疗讨论之前确定患者偏好的重要性,因为之前已确定“坏消息”的披露方式是医患面谈结果预测因素。